|
T.TH
|
I personnally don't care about the very short term stock price. I will...
|
|
T.TH
|
Simple. Come out in Q4 with excellent or spectacular efficacy results. I...
|
|
T.TH
|
Be sure that all the management and probably all employees are under a trade...
|
|
T.TH
|
I worked in a biotech for many years. I was not an insider, and regular...
|
|
T.TH
|
Interesting to hear Ed Nash say to Levesque that they were very aggressive...
|
|
T.TH
|
Can you give us a break with insider ownership! Tanguay and Pommier had a lot...
|
|
T.TH
|
Rigth at the end of the chat, Dubuc, talking about the ATM, said one...
|
|
T.TH
|
There was no specific question about the trial because I am sure they...
|
|
T.TH
|
The ball game is very different today than it was back in January. They have...
|
|
T.TH
|
I forgot that one too. So he and the board should not allow shares from the...
|
|
T.TH
|
I forgot that. He alluded twice to the possibility of spectacular results in...
|
|
T.TH
|
Nothing really new about oncology, but Levesque high enthusiasm is still...
|
|
T.TH
|
I missed that. They are also under investigation by the SEC and the...
|
|
T.TH
|
Based on preclinical data, TH1902 is checking all the boxes, but again, it is...
|
|
T.TH
|
In this previous post, I tried to look at possible negative outcomes that...
|
|
T.TH
|
He will be unable to answer medical questions #3, #4, #5, #6, #7 and #9...
|
|
T.TH
|
In oncology, we know that TH1902 works on xenograft nude mice to which...
|
|
T.TH
|
My point was never to say that Starpharma was a good investment or a better...
|
|
T.TH
|
Some can say what they want about Starpharma, but it has clear relevance...
|
|
T.TH
|
I don't understand why you are slamming them like you do. They are not...
|